Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course

Ichiro Tateya; Seiji Ishikawa; Shigeru Hirano; Morimasa Kitamura; Tatsunori Sakamoto; Juichi Ito

Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course

Ichiro Tateya, Seiji Ishikawa, Shigeru Hirano, Morimasa Kitamura, Tatsunori Sakamoto, Juichi Ito

Research output: Contribution to journal › Article › peer-review

Abstract

Transoral robotic surgery (TORS) was developed by Weinstein as a minimally invasive surgery mainly for laryngo-pharyngeal cancer. Da Vinci surgical system is a robot which enables to perform surgery safely and precisely under 3D vision. Since TORS had been cleared by FDA in 2009, it has been spreading explosively all over the world. However, it has not been approved by Pharmaceutical and Medical Devices Agency (PMDA) in Japan. We have attended the advanced course of TORS training held in Yonsei University prior to start the clinical trial of TORS and have performed radical tonsillectomy, tongue base resection, supraglottic laryngectomy, and piriform sinus resection for a cadaver. It was easy to adapt the movement of Da Vinci and transoral anatomy was a key to perform TORS safely. PMDA approval is desired in the otolaryngological field.

Original language	English
Pages (from-to)	319-323
Number of pages	5
Journal	Oto-Rhino-Laryngology Tokyo
Volume	56
Issue number	5
Publication status	Published - 01-10-2014
Externally published	Yes

All Science Journal Classification (ASJC) codes

Otorhinolaryngology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{aa07ada48a744d26ace7a7fbce886ef3,

title = "Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course",

abstract = "Transoral robotic surgery (TORS) was developed by Weinstein as a minimally invasive surgery mainly for laryngo-pharyngeal cancer. Da Vinci surgical system is a robot which enables to perform surgery safely and precisely under 3D vision. Since TORS had been cleared by FDA in 2009, it has been spreading explosively all over the world. However, it has not been approved by Pharmaceutical and Medical Devices Agency (PMDA) in Japan. We have attended the advanced course of TORS training held in Yonsei University prior to start the clinical trial of TORS and have performed radical tonsillectomy, tongue base resection, supraglottic laryngectomy, and piriform sinus resection for a cadaver. It was easy to adapt the movement of Da Vinci and transoral anatomy was a key to perform TORS safely. PMDA approval is desired in the otolaryngological field.",

author = "Ichiro Tateya and Seiji Ishikawa and Shigeru Hirano and Morimasa Kitamura and Tatsunori Sakamoto and Juichi Ito",

year = "2014",

month = oct,

day = "1",

language = "English",

volume = "56",

pages = "319--323",

journal = "Oto-Rhino-Laryngology Tokyo",

issn = "0386-9687",

publisher = "Society of Oto-Rhino-Laryngology Tokyo",

number = "5",

}

TY - JOUR

T1 - Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course

AU - Tateya, Ichiro

AU - Ishikawa, Seiji

AU - Hirano, Shigeru

AU - Kitamura, Morimasa

AU - Sakamoto, Tatsunori

AU - Ito, Juichi

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Transoral robotic surgery (TORS) was developed by Weinstein as a minimally invasive surgery mainly for laryngo-pharyngeal cancer. Da Vinci surgical system is a robot which enables to perform surgery safely and precisely under 3D vision. Since TORS had been cleared by FDA in 2009, it has been spreading explosively all over the world. However, it has not been approved by Pharmaceutical and Medical Devices Agency (PMDA) in Japan. We have attended the advanced course of TORS training held in Yonsei University prior to start the clinical trial of TORS and have performed radical tonsillectomy, tongue base resection, supraglottic laryngectomy, and piriform sinus resection for a cadaver. It was easy to adapt the movement of Da Vinci and transoral anatomy was a key to perform TORS safely. PMDA approval is desired in the otolaryngological field.

AB - Transoral robotic surgery (TORS) was developed by Weinstein as a minimally invasive surgery mainly for laryngo-pharyngeal cancer. Da Vinci surgical system is a robot which enables to perform surgery safely and precisely under 3D vision. Since TORS had been cleared by FDA in 2009, it has been spreading explosively all over the world. However, it has not been approved by Pharmaceutical and Medical Devices Agency (PMDA) in Japan. We have attended the advanced course of TORS training held in Yonsei University prior to start the clinical trial of TORS and have performed radical tonsillectomy, tongue base resection, supraglottic laryngectomy, and piriform sinus resection for a cadaver. It was easy to adapt the movement of Da Vinci and transoral anatomy was a key to perform TORS safely. PMDA approval is desired in the otolaryngological field.

UR - http://www.scopus.com/inward/record.url?scp=84896343795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896343795&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:84896343795

SN - 0386-9687

VL - 56

SP - 319

EP - 323

JO - Oto-Rhino-Laryngology Tokyo

JF - Oto-Rhino-Laryngology Tokyo

IS - 5

ER -

Transoral robotic surgery (TORS) for laryngo-pharyngeal cancer - Experience of attending TORS advanced course

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Other files and links

Fingerprint

Cite this